Is second-line anti-tuberculosis drug susceptibility testing reliable?

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 9, 2004, Pages 1157-1158

  Kim, S J ^a   Espinal, M A ^a   Abe, C ^b   Bai, G H ^c   Boulahbal, F ^d   Fattorini, L ^e   Gilpin, C ^f   Hoffner, G ^g   Kam, K M ^h   Martin Casabona, N ⁱ   Rigouts, L ^j   Vincent, V ^k  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^c Korean Institute of Tuberculosis   (South Korea)

^d Institut Pasteur d'Algerie   (Algeria)

^e Instituto Superiore de Sanita   (Italy)

^f THE PRINCE CHARLES HOSPITAL   (Australia)

^g SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^h DEPARTMENT OF HEALTH   (Hong Kong)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^k Ctr Natl Ref Mycobacteries I P   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CYCLOSERINE; ETHIONAMIDE; KANAMYCIN; OFLOXACIN; TUBERCULOSTATIC AGENT;

ANALYTIC METHOD; BACTERIUM ISOLATION; DRUG EFFECT; DRUG SENSITIVITY; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HEALTH SURVEYS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 4444298740     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Espinal M A. The global situation of MDR-TB. Tuberculosis 2003; 83: 44-51.
2. World Health Organization. Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for DOTS-Plus. WHO/CDSFFB/2001.288. WHO: Geneva, Switzerland, 2001.
3. Canetti G, Wallace F, Khomenko A, Mahler H T, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programme. Bull World Health Organ 1969; 41: 21-43.
4. Laszlo A, Rahman M, Raviglione M, Bustreo E Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231-238.
5. Laszlo A, Rahman M, Espinal M, Raviglione M. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002; 6: 748-756.